Ikuno Kawabata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ikuno Kawabata has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Katsufumi Otsuki
Department of Obstetrics and Gynecology, Showa University Koto Toyosu Hospital, Tokyo, Japan
3 shared publications Mirei Yonezawa
Department of Obstetrics and Gynecology, Graduate School of Medicine Nippon Medical School Tokyo Japan
3 shared publicationsShunji Suzuki
Department of Obstetrics and Gynecology, Graduate School of Medicine Nippon Medical School Tokyo Japan
3 shared publications- Yoshio Matsuda
Department of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi, Japan
3 shared publications Akihito Nakai
Japanese Organization of Prevention of Preterm Delivery (JOPP) Tokyo Japan
2 shared publications- Akihito Nakai
Department of Obstetrics and Gynecology, Nippon Medical School Tama-Nagayama Hospital, Tokyo, Japan
2 shared publications
Latest Publications
- 2 January 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (1) , e16198
Prolonged prothrombin time in hyperemesis gravidarum as an indicator of vitamin K deficiency
Aim: Maternal vitamin K (VK) deficiency can lead to fetal complications such as cerebral hemorrhage and bone malformations. In this study, we aimed to analyze changes in prothrombin time (PT) and protein induced by VK absence or antagonist II (PIVKA‐II) in patients with severe hyperemesis gravidarum with suspected VK deficiency.Methods: We compared 151 patients with severe hyperemesis gravidarum treated with intravenous nutrition to 46 patients undergoing cervical suturing or benign ovarian tumor surgery before mid‐pregnancy.Results: In the hyperemesis group, coagulation factors, including PT (s), prothrombin activity, INR, and APTT, showed a significant shift toward fibrinolysis compared to control (p < 0.001). The changes were within the normal range, except for PT (s), which was prolonged (14.6 ± 1.4 s). PIVKA‐II was measured 25 times in 11 cases of hyperemesis and significantly correlated with PT (s). Moreover, VK was supplemented in four cases with severe VK deficiency, promptly normalizing both PT (s) and PIVKA‐II.Conclusions: Monitoring VK deficiency using PT (s) and PIVKA‐II, with timely VK supplementation, may help prevent fetal complications in severe hyperemesis gravidarum.
- 2 January 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (1) , e16198
Prolonged prothrombin time in hyperemesis gravidarum as an indicator of vitamin K deficiency
Aim: Maternal vitamin K (VK) deficiency can lead to fetal complications such as cerebral hemorrhage and bone malformations. In this study, we aimed to analyze changes in prothrombin time (PT) and protein induced by VK absence or antagonist II (PIVKA‐II) in patients with severe hyperemesis gravidarum with suspected VK deficiency.Methods: We compared 151 patients with severe hyperemesis gravidarum treated with intravenous nutrition to 46 patients undergoing cervical suturing or benign ovarian tumor surgery before mid‐pregnancy.Results: In the hyperemesis group, coagulation factors, including PT (s), prothrombin activity, INR, and APTT, showed a significant shift toward fibrinolysis compared to control (p < 0.001). The changes were within the normal range, except for PT (s), which was prolonged (14.6 ± 1.4 s). PIVKA‐II was measured 25 times in 11 cases of hyperemesis and significantly correlated with PT (s). Moreover, VK was supplemented in four cases with severe VK deficiency, promptly normalizing both PT (s) and PIVKA‐II.Conclusions: Monitoring VK deficiency using PT (s) and PIVKA‐II, with timely VK supplementation, may help prevent fetal complications in severe hyperemesis gravidarum.
- Open Access
- 18 February 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (5) , 873-880
Nationwide status of progestogen treatment to prevent spontaneous preterm birth: A questionnaire survey for childbirth healthcare facilities in Japan
Aim: This study aimed to investigate the current status of progestogen treatment for pregnant women at a high risk for preterm birth (PTB) in childbirth healthcare facilities in Japan.Methods: A web‐based nationwide questionnaire survey regarding progestogen use for prevention of PTB was conducted among childbirth healthcare facilities from 2019 to 2021.Results: Valid responses were obtained from 528 facilities (25.2% of those surveyed), including 155 tertiary perinatal facilities (making up 92.3% of all tertiary perinatal care facilities). In the survey period, progestogen treatment was implemented in 207 facilities (39.2%) for PTB prevention. Regarding types of progestogens, 17α‐hydroxyprogesterone caproate was used in 170 facilities (82.1%), with a low dose (125 mg/week) administered in 62.9% of the facilities to comply with the regulations of the national health insurance system, although 250 mg/week is considered the best dose. Vaginal progesterone was used in 36 facilities (17.4%), although the cost of vaginal progesterone was not covered by health insurance. Of the facilities not administering progestogen treatment, approximately 40% expressed that vaginal progesterone would be their first choice for PTB prevention in daily practice if it would be covered by health insurance in the future.Conclusions: Due to the current regulations of the Japanese health insurance system, 17α‐hydroxyprogesterone caproate, rather than vaginal progesterone, was mainly used for PTB prevention. Despite global evidence supporting vaginal progesterone as the approach with the highest efficacy, only a limited number of facilities have utilized it due to the current drug use regulations in Japan.
- 18 February 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (5) , 873-880
Open AccessNationwide status of progestogen treatment to prevent spontaneous preterm birth: A questionnaire survey for childbirth healthcare facilities in Japan
Aim: This study aimed to investigate the current status of progestogen treatment for pregnant women at a high risk for preterm birth (PTB) in childbirth healthcare facilities in Japan.Methods: A web‐based nationwide questionnaire survey regarding progestogen use for prevention of PTB was conducted among childbirth healthcare facilities from 2019 to 2021.Results: Valid responses were obtained from 528 facilities (25.2% of those surveyed), including 155 tertiary perinatal facilities (making up 92.3% of all tertiary perinatal care facilities). In the survey period, progestogen treatment was implemented in 207 facilities (39.2%) for PTB prevention. Regarding types of progestogens, 17α‐hydroxyprogesterone caproate was used in 170 facilities (82.1%), with a low dose (125 mg/week) administered in 62.9% of the facilities to comply with the regulations of the national health insurance system, although 250 mg/week is considered the best dose. Vaginal progesterone was used in 36 facilities (17.4%), although the cost of vaginal progesterone was not covered by health insurance. Of the facilities not administering progestogen treatment, approximately 40% expressed that vaginal progesterone would be their first choice for PTB prevention in daily practice if it would be covered by health insurance in the future.Conclusions: Due to the current regulations of the Japanese health insurance system, 17α‐hydroxyprogesterone caproate, rather than vaginal progesterone, was mainly used for PTB prevention. Despite global evidence supporting vaginal progesterone as the approach with the highest efficacy, only a limited number of facilities have utilized it due to the current drug use regulations in Japan.
- Open Access
- 26 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12) , e6789
Preeclampsia in a pregnant woman with severe aplastic anemia: A case report
A pregnant woman with severe aplastic anemia was managed using biweekly red blood cell transfusion and oral eltrombopag olamine administration during pregnancy. She was diagnosed with preeclampsia at 35 weeks of gestation. The severity of aplastic anemia is very important for predicting the course of pregnancy.
- 26 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12) , e6789
Open AccessPreeclampsia in a pregnant woman with severe aplastic anemia: A case report
A pregnant woman with severe aplastic anemia was managed using biweekly red blood cell transfusion and oral eltrombopag olamine administration during pregnancy. She was diagnosed with preeclampsia at 35 weeks of gestation. The severity of aplastic anemia is very important for predicting the course of pregnancy.
- 25 October 2022
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 89 (5) , 520-525
Outcomes of 8 Years of Noninvasive Prenatal Testing at Nippon Medical School Hospital
BackgroundNon-invasive prenatal testing (NIPT) is a screening test for fetal chromosomal abnormalities, such as fetal aneuploidy, and has been offered at our hospital since 2013. We aimed to assess whether applicants for NIPT could be given more accurate information regarding NIPT outcomes after assessing the data from our center.MethodsThis retrospective observational study included 819 pregnant women who requested NIPT at Nippon Medical School Hospital from November 2013 to October 2021. We examined data on NIPT results and clinical outcomes from medical records.ResultsOf the 819 women, 764 (93.2%) underwent NIPT, and 55 (6.7%) did not. Of the 764 women who underwent NIPT, there were 17 with positive results (2.2%), of whom 2 (11.8%), 4 (23.5%), and 11 (64.7%) tested positive for trisomy 13, 18, and 21, respectively. The true-positive rates after definitive diagnoses of trisomy 13, 18, and 21 were 1 (50%), 3 (75%), and 11 (100%), respectively. Of the 17 positive results, there were two false-positives was (11.8%) (for trisomy 13 and trisomy 18). Eleven women with fetal aneuploidy terminated their pregnancies, and four cases resulted in intrauterine fetal demise. Two patients had undeterminable results from the first blood sampling, possibly due to unfractionated heparin treatment, and repeat tests after ceasing heparin treatment were negative.ConclusionsOur results were generally similar to nationwide data of Japan. Providers for NIPT can give more detailed and individualized genetic counseling for each situation if the data of their facility is taken into account.
- 25 October 2022
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 89 (5) , 520-525
Outcomes of 8 Years of Noninvasive Prenatal Testing at Nippon Medical School Hospital
BackgroundNon-invasive prenatal testing (NIPT) is a screening test for fetal chromosomal abnormalities, such as fetal aneuploidy, and has been offered at our hospital since 2013. We aimed to assess whether applicants for NIPT could be given more accurate information regarding NIPT outcomes after assessing the data from our center.MethodsThis retrospective observational study included 819 pregnant women who requested NIPT at Nippon Medical School Hospital from November 2013 to October 2021. We examined data on NIPT results and clinical outcomes from medical records.ResultsOf the 819 women, 764 (93.2%) underwent NIPT, and 55 (6.7%) did not. Of the 764 women who underwent NIPT, there were 17 with positive results (2.2%), of whom 2 (11.8%), 4 (23.5%), and 11 (64.7%) tested positive for trisomy 13, 18, and 21, respectively. The true-positive rates after definitive diagnoses of trisomy 13, 18, and 21 were 1 (50%), 3 (75%), and 11 (100%), respectively. Of the 17 positive results, there were two false-positives was (11.8%) (for trisomy 13 and trisomy 18). Eleven women with fetal aneuploidy terminated their pregnancies, and four cases resulted in intrauterine fetal demise. Two patients had undeterminable results from the first blood sampling, possibly due to unfractionated heparin treatment, and repeat tests after ceasing heparin treatment were negative.ConclusionsOur results were generally similar to nationwide data of Japan. Providers for NIPT can give more detailed and individualized genetic counseling for each situation if the data of their facility is taken into account.
- Open Access
- 5 August 2022
- Published by Wiley
Preeclampsia in a pregnant woman with severe aplastic anemia: a case report
A pregnant woman with severe aplastic anemia was managed using biweekly red blood cell transfusion and oral eltrombopag olamine administration during pregnancy. She was diagnosed with severe preeclampsia at 35 weeks of gestation. The severity of aplastic anemia is very important for predicting the course of pregnancy.
- 5 August 2022
- Published by Wiley
Open AccessPreeclampsia in a pregnant woman with severe aplastic anemia: a case report
A pregnant woman with severe aplastic anemia was managed using biweekly red blood cell transfusion and oral eltrombopag olamine administration during pregnancy. She was diagnosed with severe preeclampsia at 35 weeks of gestation. The severity of aplastic anemia is very important for predicting the course of pregnancy.
- Open Access
- 11 September 2018
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 45 (1) , 86-95
Randomized trial of the efficacy of intravaginal ulinastatin administration for the prevention of preterm birth in women with a singleton pregnancy and both cervical shortening and inflammation of lower genital tract
Aim: To assess the preventive effect on preterm birth of intravaginal ulinastatin (urinary trypsin inhibitor; UTI) administration during the mid‐trimester in women with singleton pregnancy and both cervical shortening and lower genital infections.Methods: Pregnant women with a short cervical length < 25 mm between 16 and 26 weeks of gestation and who had been diagnosed with a lower genital infection were randomly assigned for intravaginal UTI administration or placebo. All of the women were screened for infection or inflammation of the lower genital tract, and women with negative results were excluded.Results: Of the 92 patients with a short cervical length who were assessed for eligibility for this study, 86 singleton patients were enrolled. All patients were randomized to one of two treatment groups: patients administered UTI (n = 35) and placebo (n = 35). There were no differences between the two groups in the incidence of preterm delivery before 28, 30, 32, 34 and 37 weeks of gestation and in perinatal outcomes.Conclusion: For women diagnosed with a short cervical length < 25 mm) between 16 and 26 weeks of gestation and lower genital infection, who were at risk of preterm birth, administration of transvaginal UTI with vaginal irrigation showed no apparent benefit. Future research on the efficacy of UTI should evaluate modified modes of UTI application.
- 11 September 2018
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 45 (1) , 86-95
Open AccessRandomized trial of the efficacy of intravaginal ulinastatin administration for the prevention of preterm birth in women with a singleton pregnancy and both cervical shortening and inflammation of lower genital tract
Aim: To assess the preventive effect on preterm birth of intravaginal ulinastatin (urinary trypsin inhibitor; UTI) administration during the mid‐trimester in women with singleton pregnancy and both cervical shortening and lower genital infections.Methods: Pregnant women with a short cervical length < 25 mm between 16 and 26 weeks of gestation and who had been diagnosed with a lower genital infection were randomly assigned for intravaginal UTI administration or placebo. All of the women were screened for infection or inflammation of the lower genital tract, and women with negative results were excluded.Results: Of the 92 patients with a short cervical length who were assessed for eligibility for this study, 86 singleton patients were enrolled. All patients were randomized to one of two treatment groups: patients administered UTI (n = 35) and placebo (n = 35). There were no differences between the two groups in the incidence of preterm delivery before 28, 30, 32, 34 and 37 weeks of gestation and in perinatal outcomes.Conclusion: For women diagnosed with a short cervical length < 25 mm) between 16 and 26 weeks of gestation and lower genital infection, who were at risk of preterm birth, administration of transvaginal UTI with vaginal irrigation showed no apparent benefit. Future research on the efficacy of UTI should evaluate modified modes of UTI application.
- Open Access
- 30 November 2017
- Published by Japan Society for the Study of Hypertension in Pregnancy in Hypertension Research in Pregnancy
- Vol. 5 (2) , 36-38
Home blood pressure measurement (HBPM) for the early detection of hypertensive disorders of pregnancy (HDP) in Japanese women: a multicenter prospective study
A multicenter study on home blood pressure measurement (HBPM) targeting Japanese pregnant women by the Japan Society for the Study of Hypertension in Pregnancy (JSSHP) has been ongoing since 2016. To date, over 200 pregnant women have been enrolled. This is an interim report.
- 30 November 2017
- Published by Japan Society for the Study of Hypertension in Pregnancy in Hypertension Research in Pregnancy
- Vol. 5 (2) , 36-38
Open AccessHome blood pressure measurement (HBPM) for the early detection of hypertensive disorders of pregnancy (HDP) in Japanese women: a multicenter prospective study
A multicenter study on home blood pressure measurement (HBPM) targeting Japanese pregnant women by the Japan Society for the Study of Hypertension in Pregnancy (JSSHP) has been ongoing since 2016. To date, over 200 pregnant women have been enrolled. This is an interim report.
- 3 May 2016
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 41 (2) , 145-151
Improving the Accuracy of Diagnosing Placenta Previa on Transvaginal Ultrasound by Distinguishing between the Uterine Isthmus and Cervix: A Prospective Multicenter Observational Study
Objective: To clarify whether distinguishing between the uterine isthmus and cervix can improve the accuracy of diagnosing placenta previa at term. Methods: A multicenter prospective observational study was conducted among pregnant women with suspected placenta previa at 20-24 weeks' gestation. Subjects were divided into the open isthmus group and closed isthmus group. The accuracy of diagnosing placenta previa at term was compared between the 2 groups. Results: We screened 9,341 patients, and 53 (0.6%) met the inclusion criteria. Nineteen cases with an open isthmus and 34 with a closed isthmus were followed. The accuracy for diagnosing placenta previa or a low-lying placenta at term was 94.7% in the open isthmus group and 26.5% in the closed isthmus group (p < 0.001). Elective or emergency Cesarean section was required in 100% of cases in the open isthmus group and 20.6% in the closed isthmus group (p < 0.001). Conclusion: A high prediction rate of placenta previa was obtained by using transvaginal ultrasound at 20-24 weeks' gestation after the isthmus opened by carefully distinguishing between the cervix and isthmus.
- 3 May 2016
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 41 (2) , 145-151
Improving the Accuracy of Diagnosing Placenta Previa on Transvaginal Ultrasound by Distinguishing between the Uterine Isthmus and Cervix: A Prospective Multicenter Observational Study
Objective: To clarify whether distinguishing between the uterine isthmus and cervix can improve the accuracy of diagnosing placenta previa at term. Methods: A multicenter prospective observational study was conducted among pregnant women with suspected placenta previa at 20-24 weeks' gestation. Subjects were divided into the open isthmus group and closed isthmus group. The accuracy of diagnosing placenta previa at term was compared between the 2 groups. Results: We screened 9,341 patients, and 53 (0.6%) met the inclusion criteria. Nineteen cases with an open isthmus and 34 with a closed isthmus were followed. The accuracy for diagnosing placenta previa or a low-lying placenta at term was 94.7% in the open isthmus group and 26.5% in the closed isthmus group (p < 0.001). Elective or emergency Cesarean section was required in 100% of cases in the open isthmus group and 20.6% in the closed isthmus group (p < 0.001). Conclusion: A high prediction rate of placenta previa was obtained by using transvaginal ultrasound at 20-24 weeks' gestation after the isthmus opened by carefully distinguishing between the cervix and isthmus.
- Open Access
- 1 January 2010
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 77 (6) , 290-295
Factors Influencing the Accuracy of Digital Examination for Determining Fetal Head Position during the First Stage of Labor
Objective: The objective of this study was to explore factors influencing the accuracy of transvaginal digital examination for determining fetal head position during the first stage of labor. Materials and Methods: Fetal head position was assessed in 87 women in the first stage of labor at term with normal singleton cephalic presentation. Transvaginal digital examinations were performed by attending midwives and were followed immediately by transabdominal ultrasound assessments performed by a single sonographer. Accuracy was defined as agreement of the results of each examination. Multivariate logistic regression analysis was performed to determine the independent factors influencing accuracy. Results: In only 40.3% of patients (n = 35) were transvaginal digital examinations consistent with ultrasound assessments. Multivariate logistic regression analysis showed that the accuracy of digital examinations was significantly associated with cervical dilatation more than 7 cm (odds ratio, 3.01; 95% confidence interval [CI], 1.03-9.4), birth weight less than 2,500 g (odds ratio, 8.68; 95% CI, 1.08-86.28), and the anterior occiput position group (odds ratio, 4.73; 95% CI, 1.76-13.49). Conclusions: The present study demonstrates that transvaginal digital examination is less accurate than ultrasonography for determining fetal head position during the first stage of labor. The results suggest that ultrasound assessments should be routinely performed in patients with a cervical dilatation less than 7 cm, an estimated fetal body weight more than 2,500 g, the occiput posterior position, or the occiput transverse position.
- 1 January 2010
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 77 (6) , 290-295
Open AccessFactors Influencing the Accuracy of Digital Examination for Determining Fetal Head Position during the First Stage of Labor
Objective: The objective of this study was to explore factors influencing the accuracy of transvaginal digital examination for determining fetal head position during the first stage of labor. Materials and Methods: Fetal head position was assessed in 87 women in the first stage of labor at term with normal singleton cephalic presentation. Transvaginal digital examinations were performed by attending midwives and were followed immediately by transabdominal ultrasound assessments performed by a single sonographer. Accuracy was defined as agreement of the results of each examination. Multivariate logistic regression analysis was performed to determine the independent factors influencing accuracy. Results: In only 40.3% of patients (n = 35) were transvaginal digital examinations consistent with ultrasound assessments. Multivariate logistic regression analysis showed that the accuracy of digital examinations was significantly associated with cervical dilatation more than 7 cm (odds ratio, 3.01; 95% confidence interval [CI], 1.03-9.4), birth weight less than 2,500 g (odds ratio, 8.68; 95% CI, 1.08-86.28), and the anterior occiput position group (odds ratio, 4.73; 95% CI, 1.76-13.49). Conclusions: The present study demonstrates that transvaginal digital examination is less accurate than ultrasonography for determining fetal head position during the first stage of labor. The results suggest that ultrasound assessments should be routinely performed in patients with a cervical dilatation less than 7 cm, an estimated fetal body weight more than 2,500 g, the occiput posterior position, or the occiput transverse position.